Sea Island Cotton Fusarium Wilt Resistance Protein GbOFP7 and Its Coding Gene and Application
By providing GbOFP7 protein and its encoding gene, the shortcomings of the island cotton blight resistance research have been solved, and the effect of significantly improving or reducing blight resistance through genetically modified technology is achieved, providing a new method for controlling plant blight resistance .
Patent Information
- Application Number
- CN202311536930.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-17
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2043-11-17
AI Technical Summary
There are very few studies on the resistance to blight in island cotton, and the molecular mechanism of blight resistance is unclear. It is difficult for the prior art to effectively regulate the blight resistance of plants.
Provide a protein GbOFP7 and its encoding gene, obtained by artificial synthesis or biological expression, for regulating plant blight resistance, including through modification of amino acid sequences, tag fusion and application of biological materials, for the construction of recombinant vectors and transgenic plants. to increase or decrease blight resistance.
Through the application of GbOFP7 protein and genes, the resistance of island cotton to blight is significantly improved or reduced, the resistance of plants to blight is enhanced, and a new method to regulate plant blight resistance is provided.
Smart Images

Figure HDA0004555317260000011 
Figure HDA0004555317260000012 
Figure HDA0004555317260000013
Abstract
Description
Technical Field
[0001] The invention relates to the field of botany, and in particular to a sea island cotton wilt resistance protein GbOFP7 and a coding gene and application thereof. Background Art
[0002] Fusarium wilt is one of the major diseases threatening global cotton production. It can occur throughout the entire growth period of Sea Island cotton. Sea Island cotton fiber is of excellent quality, long, thin and strong, and is an indispensable raw material for high-count combed yarn and special fabrics. The occurrence of Fusarium wilt seriously affects the yield and quality of Sea Island cotton, but there is very little research on Sea Island cotton Fusarium wilt resistance, and the molecular mechanism of Sea Island cotton resistance to Fusarium wilt is also unclear. Identifying and cloning Sea Island cotton Fusarium wilt resistance genes will help us understand the molecular mechanism of Sea Island cotton resistance to Fusarium wilt.
[0003] Oval family proteins (OFPs) are plant-specific growth regulators that regulate cell elongation and secondary cell wall formation by inhibiting the expression of downstream target genes. In addition, OFP genes are also associated with drought resistance, cold tolerance, and salt tolerance. However, there are no reports on OFP proteins regulating the resistance of sea island cotton to Fusarium wilt. Summary of the invention
[0004] The technical problem to be solved by the present invention is how to regulate the resistance of plants to wilt disease.
[0005] In order to solve the problems existing in the prior art, the present invention provides a protein.
[0006] The protein provided by the present invention may be any of the following proteins:
[0007] A1) a protein with an amino acid sequence as shown in SEQ ID No. 3;
[0008] A2) a protein having more than 80% identity with the protein shown in A1) and having the function of regulating plant wilt resistance obtained by replacing and / or deleting and / or adding amino acid residues of the protein shown in A1); for example, a person skilled in the art can obtain a protein mutant having the same function as the amino acid sequence shown in SEQ ID No. 3 by replacing, deleting and / or adding one or more amino acids without affecting its activity according to the amino acid sequence shown in SEQ ID No. 3 and conventional technical means in the art such as conservative substitution of amino acids;
[0009] A3) A fusion protein obtained by connecting a protein tag to the N-terminus and / or C-terminus of A1) or A2).
[0010] The name of the protein described in A1) above is GbOFP7.
[0011] In order to facilitate purification or detection of the protein in A1), a tag protein may be connected to the amino terminus or carboxyl terminus of the protein consisting of the amino acid sequence shown in SEQ ID No. 3 in the sequence listing.
[0012] The above proteins can be artificially synthesized, or their encoding genes can be synthesized first and then expressed biologically.
[0013] The tag protein includes but is not limited to: GST (glutathione sulfhydryltransferase) tag protein, His6 tag protein (His-tag), MBP (maltose binding protein) tag protein, Flag tag protein, SUMO tag protein, HA tag protein, Myc tag protein, eGFP (enhanced green fluorescent protein), eCFP (enhanced cyan fluorescent protein), eYFP (enhanced yellow-green fluorescent protein), mCherry (monomeric red fluorescent protein) or AviTag tag protein.
[0014] A person skilled in the art can easily mutate the nucleotide sequence encoding the protein GbOFP7 of the present invention by using known methods, such as directed evolution or point mutation. Those artificially modified nucleotides having 75% or more identity with the nucleotide sequence of the protein GbOFP7 isolated by the present invention are all derived from the nucleotide sequence of the present invention and are equivalent to the sequence of the present invention as long as they encode the protein GbOFP7 and have the function of the protein GbOFP7.
[0015] The aforementioned 75% or more identity may be 80%, 85%, 90% or 95% or more identity.
[0016] Herein, identity refers to the identity of an amino acid sequence or a nucleotide sequence. The identity of an amino acid sequence can be determined using a homology search site on the Internet, such as the BLAST webpage on the NCBI homepage website. For example, in Advanced BLAST2.1, by using blastp as a program, setting the Expect value to 10, setting all Filters to OFF, using BLOSUM62 as a Matrix, setting Gap existence cost, Per residue gap cost and Lambda ratio to 11, 1 and 0.85 (default values) respectively and searching for the identity of a pair of amino acid sequences for calculation, the value (%) of identity can then be obtained.
[0017] Herein, the 80% or greater identity may be at least 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity.
[0018] Herein, the 90% or greater identity may be at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity.
[0019] In the above, the protein is derived from Gossypium barbadense L.
[0020] The present invention also provides a biological material related to the above protein, and the biological material may be any one of the following:
[0021] B1) a nucleic acid molecule encoding the protein described above;
[0022] B2) an expression cassette containing the nucleic acid molecule described in B1);
[0023] B3) a recombinant vector containing the nucleic acid molecule described in B1), or a recombinant vector containing the expression cassette described in B2);
[0024] B4) a recombinant microorganism containing the nucleic acid molecule described in B1), or a recombinant microorganism containing the expression cassette described in B2), or a recombinant microorganism containing the recombinant vector described in B3);
[0025] B5) a transgenic plant cell line containing the nucleic acid molecule described in B1) or a transgenic plant cell line containing the expression cassette described in B2);
[0026] B6) transgenic plant tissue containing the nucleic acid molecule described in B1) or transgenic plant tissue containing the expression cassette described in B2);
[0027] B7) a transgenic plant organ containing the nucleic acid molecule described in B1) or a transgenic plant organ containing the expression cassette described in B2);
[0028] C1) a nucleic acid molecule that inhibits, reduces or silences the expression of a gene encoding the protein described above;
[0029] C2) expressing the gene encoding the nucleic acid molecule described in C1);
[0030] C3) an expression cassette containing the coding gene described in C2);
[0031] C4) a recombinant vector containing the coding gene described in C2) or a recombinant vector containing the expression cassette described in C3);
[0032] C5) a recombinant microorganism containing the coding gene described in C2), or a recombinant microorganism containing the expression cassette described in C3), or a recombinant microorganism containing the recombinant vector described in C4);
[0033] C6) a transgenic plant cell line containing the coding gene described in C2), or a transgenic plant cell line containing the expression cassette described in C3), or a transgenic plant cell line containing the recombinant vector described in C4);
[0034] C7) transgenic plant tissue containing the coding gene described in C2), or transgenic plant tissue containing the expression cassette described in C3), or transgenic plant tissue containing the recombinant vector described in C4);
[0035] C8) A transgenic plant organ containing the coding gene described in C2), or a transgenic plant organ containing the expression cassette described in C3), or a transgenic plant organ containing the recombinant vector described in C4).
[0036] In the above biological material, the nucleic acid molecule described in B1) is the gene shown in E1) or E2) below:
[0037] E1) the coding sequence is a cDNA molecule or a DNA molecule of SEQ ID No. 1;
[0038] E2) The nucleotide sequence is a cDNA molecule or a DNA molecule of SEQ ID No.2.
[0039] The DNA molecule shown in SEQ ID No.1 (GbOFP7 gene regulating plant disease resistance) encodes a protein with an amino acid sequence of SEQ ID No.3.
[0040] The nucleotide sequence shown in SEQ ID No. 1 is the nucleotide sequence of the protein GbOFP7 encoding gene (CDS).
[0041] The nucleotide sequence shown in SEQ ID No. 2 is the nucleotide sequence of the genome of protein GbOFP7.
[0042] The GbOFP7 gene of the present invention can be any nucleotide sequence capable of encoding the protein GbOFP7. Considering the degeneracy of codons and the preference of codons of different species, those skilled in the art can use codons suitable for expression of a specific species as needed.
[0043] B1) The nucleic acid molecule may also include a nucleic acid molecule obtained by modifying the codon preference based on the nucleotide sequence shown in SEQ ID No. 1.
[0044] B1) The nucleic acid molecule may also include a nucleic acid molecule having a nucleotide sequence identity of more than 95% with the nucleotide sequence shown in SEQ ID No. 1 and originating from the same species.
[0045] The nucleic acid molecule described herein can be DNA, such as cDNA, genomic DNA or recombinant DNA; the nucleic acid molecule can also be RNA, such as gRNA, mRNA, siRNA, shRNA, sgRNA, miRNA or antisense RNA.
[0046] The vectors described herein are well known to those skilled in the art, including but not limited to: plasmid, phage (such as lambda phage or M13 filamentous phage, etc.), cosmid (i.e., cosmid), Ti plasmid or viral vector, and specifically may be vectors pCLCrVA and p35S::GFP vectors.
[0047] The existing plant expression vector can be used to construct a recombinant expression vector containing the GbOFP7 gene. The plant expression vector includes, but is not limited to, binary Agrobacterium vectors and vectors that can be used for plant microprojectile bombardment. The plant expression vector may also include the 3' non-translated region of the foreign gene, i.e., a polyadenylic acid signal and any other DNA fragments involved in mRNA processing or gene expression. The polyadenylic acid signal can guide the addition of polyadenylic acid to the 3' end of the mRNA precursor, such as, but not limited to, Agrobacterium crown gall induction (Ti) plasmid genes (such as rouge synthase Nos gene), plant genes (such as soybean storage protein gene) 3' end transcription non-translated regions have similar functions.
[0048] When using the GbOFP7 gene to construct a recombinant plant expression vector, any enhanced promoter or constitutive promoter can be added before its transcription initiation nucleotide, including but not limited to cauliflower mosaic virus (CAMV) 35S promoter, corn ubiquitin promoter (ubiquitin), which can be used alone or in combination with other plant promoters; in addition, when using the gene of the present invention to construct a plant expression vector, enhancers can also be used, including translation enhancers or transcription enhancers, and these enhancer regions can be ATG start codons or adjacent region start codons, etc., but must be the same as the reading frame of the coding sequence to ensure the correct translation of the entire sequence. The sources of the translation control signal and the start codon are extensive, and can be natural or synthetic. The translation initiation region can come from the transcription initiation region or the structural gene.
[0049] In order to facilitate the identification and screening of transgenic plant cells or plants, the plant expression vector used can be processed, such as adding genes that can be expressed in plants and encode enzymes or luminescent compounds that can produce color changes (GUS gene, luciferase gene, etc.), antibiotic markers with resistance (gentamicin marker, kanamycin marker, etc.) or chemical agent resistance marker genes (such as herbicide resistance genes), etc. Considering the safety of transgenic plants, no selective marker genes can be added, and transformed plants can be directly screened by adversity.
[0050] By using any vector that can guide the expression of foreign genes in plants, the GbOFP7 gene or gene fragment provided by the present invention is introduced into plant cells or recipient plants, and transgenic cell lines and transgenic plants with altered resistance to plant wilt disease can be obtained. The expression vector carrying the GbOFP7 gene can be transformed into plant cells or tissues by conventional biological methods such as Ti plasmids, Ri plasmids, plant virus vectors, direct DNA transformation, microinjection, electroporation, Agrobacterium-mediated, etc., and the transformed plant tissues can be cultivated into plants.
[0051] As a specific embodiment, the above-mentioned recombinant vector is the recombinant vector pCLCrVA-GbOFP7. The recombinant vector pCLCrVA-GbOFP7 is a recombinant vector obtained by replacing the fragment between the Spe I and Pac I recognition sites of the pCLCrVA vector (starting vector) sequence with the DNA molecule shown in SEQ ID No.4, while keeping the other nucleotides of the pCLCrVA vector (starting vector) unchanged.
[0052] As a specific embodiment, the above-mentioned recombinant vector is the recombinant vector p35S::GbOFP7-GFP.
[0053] The recombinant vector p35S::GbOFP7-GFP is a recombinant expression vector obtained by replacing the small fragment between the restriction endonuclease Kpn I and XbaI recognition sequences of the plasmid p35S::GFP with the DNA molecule shown in sequence 1 in the sequence table (excluding the stop codon TGA) while keeping the other sequences of the p35S::GFP vector unchanged.
[0054] The recombinant plasmid p35S::GbOFP7-GFP expresses the GbOFP7 protein shown in Sequence 3 in the sequence table. The recombinant plasmid p35S::GbOFP7-GFP contains an expression cassette of the GbOFP7-GFP fusion protein, and the promoter for initiating transcription of the GbOFP7 gene in the expression cassette is the 35S promoter.
[0055] The recombinant microorganism may specifically be recombinant Agrobacterium GV3101 / GbOFP7-GFP.
[0056] The recombinant Agrobacterium GV3101 / GbOFP7-GFP is a recombinant bacterium obtained by introducing the recombinant vector p35S::GbOFP7-GFP into Agrobacterium tumefaciens GV3101.
[0057] The microorganism described herein may be yeast, bacteria, algae or fungi. Among them, the bacteria may be from Escherichia, Erwinia, Agrobacterium, Flavobacterium, Alcaligenes, Pseudomonas, Bacillus, etc. Specifically, it may be Agrobacterium tumefaciens GV3101.
[0058] The present invention also provides the use of the above-mentioned protein GbOFP7 or a substance regulating the expression of a gene or a substance regulating the activity or content of the protein in any of the following:
[0059] U1) Use of the protein or the substance regulating the expression of the gene or the substance regulating the activity or content of the protein in regulating plant resistance to wilt disease;
[0060] U2) Use of the protein or the substance regulating the expression of the gene or the substance regulating the activity or content of the protein in the preparation of a product regulating plant resistance to Fusarium wilt;
[0061] U3) Use of the protein or the substance regulating the expression of the gene or the substance regulating the activity or content of the protein in cultivating plants resistant to plant wilt disease;
[0062] U4) Use of the protein or the substance regulating the expression of the gene or the substance regulating the activity or content of the protein in the preparation of products for cultivating plants resistant to wilt disease;
[0063] U5) Use of the protein or the substance regulating gene expression or the substance regulating the activity or content of the protein in plant breeding.
[0064] Herein, the substance that regulates the activity and / or content of the protein may be a substance that regulates the expression of a gene, the gene encoding the protein GbOFP7.
[0065] In the above application, the substance regulating gene expression or the substance regulating the activity or content of the protein is a biological material related to the protein, and the biological material can be any one of the following:
[0066] B1) a nucleic acid molecule encoding the protein described above;
[0067] B2) an expression cassette containing the nucleic acid molecule described in B1);
[0068] B3) a recombinant vector containing the nucleic acid molecule described in B1), or a recombinant vector containing the expression cassette described in B2);
[0069] B4) a recombinant microorganism containing the nucleic acid molecule described in B1), or a recombinant microorganism containing the expression cassette described in B2), or a recombinant microorganism containing the recombinant vector described in B3);
[0070] B5) a transgenic plant cell line containing the nucleic acid molecule described in B1) or a transgenic plant cell line containing the expression cassette described in B2);
[0071] B6) transgenic plant tissue containing the nucleic acid molecule described in B1) or transgenic plant tissue containing the expression cassette described in B2);
[0072] B7) a transgenic plant organ containing the nucleic acid molecule described in B1) or a transgenic plant organ containing the expression cassette described in B2);
[0073] C1) a nucleic acid molecule that inhibits, reduces or silences the expression of a gene encoding the protein described above;
[0074] C2) expressing the gene encoding the nucleic acid molecule described in C1);
[0075] C3) an expression cassette containing the coding gene described in C2);
[0076] C4) a recombinant vector containing the coding gene described in C2) or a recombinant vector containing the expression cassette described in C3);
[0077] C5) a recombinant microorganism containing the coding gene described in C2), or a recombinant microorganism containing the expression cassette described in C3), or a recombinant microorganism containing the recombinant vector described in C4);
[0078] C6) a transgenic plant cell line containing the coding gene described in C2), or a transgenic plant cell line containing the expression cassette described in C3), or a transgenic plant cell line containing the recombinant vector described in C4);
[0079] C7) transgenic plant tissue containing the coding gene described in C2), or transgenic plant tissue containing the expression cassette described in C3), or transgenic plant tissue containing the recombinant vector described in C4);
[0080] C8) A transgenic plant organ containing the coding gene described in C2), or a transgenic plant organ containing the expression cassette described in C3), or a transgenic plant organ containing the recombinant vector described in C4).
[0081] In the above, the substance that regulates gene expression may be a substance that performs at least one of the following six types of regulation: 1) regulation at the transcription level of the gene; 2) regulation after transcription of the gene (that is, regulation of the splicing or processing of the primary transcript of the gene); 3) regulation of RNA transport of the gene (that is, regulation of the transport of the mRNA of the gene from the nucleus to the cytoplasm); 4) regulation of the translation of the gene; 5) regulation of the degradation of the mRNA of the gene; 6) post-translational regulation of the gene (that is, regulation of the activity of the protein translated from the gene).
[0082] The present invention also provides a method for regulating plant resistance to Fusarium wilt, comprising regulating the activity and / or content of the protein described above in the target plant, or / and the expression level of the gene encoding the protein, to regulate the resistance to Fusarium wilt in the plant.
[0083] In the above method, the regulation of the activity and / or content of the protein GbOFP7 in the target plant, or / and the expression level of the gene encoding the protein includes introducing the gene encoding the protein GbOFP7 into the recipient plant to obtain the target plant with altered resistance to plant wilt disease; the GbOFP7 encoding gene encodes the protein GbOFP7.
[0084] The introduction refers to introduction by recombinant means, including but not limited to Agrobacterium-mediated transformation, biolistic methods, electroporation, in planta technology, and the like.
[0085] In the above-mentioned applications and methods, the regulation may be increasing, enhancing or up-regulating.
[0086] In the above-mentioned uses and methods, the regulation may be inhibition, reduction or silencing.
[0087] In order to facilitate the identification and screening of transgenic cells or plants, the recombinant expression vector used can be processed, such as adding genes that can be expressed in plants and encode enzymes or luminescent compounds that can produce color reactions, antibiotic markers with resistance, or chemical agent resistance marker genes. It is also possible not to add any selective marker genes and directly screen the transformed plants by adversity. The plants obtained by the above method can be transgenic plants, or they can be plants obtained by conventional breeding techniques such as hybridization. In the above method, the transgenic plants are understood to include not only the first to second generation transgenic plants, but also their progeny. For transgenic plants, the gene can be propagated in the species, and the gene can also be transferred into other varieties of the same species using conventional breeding techniques, especially including commercial varieties. The transgenic plants include seeds, callus tissues, complete plants and cells.
[0088] The present invention also provides a method for cultivating plants with altered resistance to plant wilt disease, comprising: 1) inhibiting or reducing or silencing the expression level of the gene encoding the protein mentioned above in the target plant, or / and inhibiting or reducing or silencing the activity and / or content of the gene encoding the protein mentioned above, to obtain plants with improved wilt disease resistance; 2) increasing, enhancing and / or up-regulating the expression level of the gene encoding the protein mentioned above in the target plant, or / and increasing, enhancing and / or up-regulating the activity and / or content of the gene encoding the protein mentioned above, to obtain plants with reduced resistance to wilt disease.
[0089] As an embodiment of the present invention, the method for cultivating plants resistant to wilt disease comprises the following steps:
[0090] (1) constructing a recombinant expression vector for inhibiting, reducing or silencing the gene encoding the protein described above (the amino acid sequence of the protein is Sequence 3);
[0091] (2) introducing the expression vector constructed in step (1) into the plant;
[0092] (3) Obtain plants resistant to Fusarium wilt through screening and identification.
[0093] In a specific embodiment, a method for cultivating plants with improved resistance to wilt disease comprises the following steps: inhibiting the expression of a nucleic acid molecule encoding a GbOFP7 protein in a target plant to obtain a transgenic plant with improved resistance to wilt disease. The inhibition of the expression of a nucleic acid molecule encoding a GbOFP7 protein in a target plant can be achieved by introducing an interference vector targeting a nucleic acid molecule encoding a GbOFP7 protein into the target plant. The inhibition of the expression of a nucleic acid molecule encoding a GbOFP7 protein in a target plant can be achieved by introducing a gene silencing vector targeting a nucleic acid molecule encoding a GbOFP7 protein into the target plant.
[0094] The gene silencing vector can be a recombinant vector pCLCrVA-GbOFP7. The recombinant vector pCLCrVA-GbOFP7 is a recombinant vector obtained by replacing the fragment between the SpeI and Pac I recognition sites of the pCLCrVA vector (starting vector) sequence with the DNA molecule shown in SEQ ID No.4, while keeping the other nucleotides of the pCLCrVA vector (starting vector) unchanged.
[0095] The present invention also provides a method for cultivating plants with improved resistance to wilt disease, comprising the following steps: inhibiting or reducing or silencing the expression level of the gene encoding the protein mentioned above in the target plant, or / and inhibiting or reducing or silencing the activity and / or content of the gene encoding the protein mentioned above, to obtain plants with improved resistance to wilt disease.
[0096] In the present invention, the purpose of plant breeding includes cultivating plants resistant to Fusarium wilt disease.
[0097] In the above application or method, the plant is any one of the following:
[0098] N1) dicotyledonous plants;
[0099] N2) Malvaceae;
[0100] N3) Malvaceae;
[0101] N4) cotton plants;
[0102] N5) Cotton.
[0103] In the above, the cotton may be Gossypium barbadense L. susceptible variety II15-3465.
[0104] The invention uses a natural population of sea island cotton to identify the incidence of wilt disease and locates the sea island cotton wilt resistance genetic locus at position 1110567 of chromosome D03 through genome-wide association analysis. A gene GbOFP7 is identified 22.6 kb downstream thereof, and a G to C non-synonymous mutation (Gbar_D03_1134219) exists on its only exon. Among them, the incidence of wilt disease of sea island cotton varieties carrying the C variant is significantly lower than that of varieties carrying the G variant. GbOFP7 is expressed higher in susceptible sea island cotton varieties than in resistant sea island cotton varieties. After reducing the expression of GbOFP7 in susceptible sea island cotton using virus-induced gene silencing (VIGS) technology, wilt resistance is significantly enhanced and plant height is increased. The gene encodes a transcriptional repressor of an ovoid family protein, is mainly located on the membrane and the nucleus, is a new type of sea island cotton wilt resistance gene, and has certain theoretical and application values. BRIEF DESCRIPTION OF THE DRAWINGS
[0105] Figure 1 This is the distribution map of the average wilt incidence of sea island cotton populations surveyed in disease nurseries in Xinjiang Uygur Autonomous Region, China in 2015, 2016, 2018 and 2019.
[0106] Figure 2The overall (a) and local Manhattan plots (b) of the incidence of Fusarium wilt in the Sea Island cotton population material. a is the overall Manhattan plot of the incidence of Fusarium wilt in the Sea Island cotton population material, with the arrow marking the extremely significant associated SNP (Gbar_D03_1110567) located; b is the local Manhattan plot of the incidence of Fusarium wilt in the Sea Island cotton population material, with the arrow marking the non-synonymous SNP (Gbar_D03_1134219) within the extremely significant associated gene.
[0107] Figure 3 The positions of non-synonymous mutations in the GbOFP7 gene. The blue and yellow rectangles represent the untranslated region (UTR) and the coding region (CDS), respectively, and the black lines represent introns. Ref GGT (G) indicates that the reference codon GGT encodes glycine (abbreviated as G), and the key mutation site is the second G in the middle; Alt GCT (A) indicates that the variant codon GCT encodes alanine (abbreviated as A), and the key mutation site is the second C in the middle, that is, guanine (G) mutates to cytosine (C), resulting in the amino acid changing from glycine to alanine.
[0108] Figure 4 The incidence of Fusarium wilt in Sea Island cotton varieties carrying two types of GbOFP7 mutations.
[0109] Figure 5 Bar graph showing the differential expression of GbOFP7 in Fusarium wilt-resistant variety T10-280 and Fusarium wilt-susceptible variety II15-3464 detected by qRT-PCR and the expression level of GbOFP7 after VIGS in Fusarium wilt-susceptible varieties. R_WT represents the wild-type control of Fusarium wilt-resistant variety T10-280, and S_WT represents the wild-type control of Fusarium wilt-susceptible variety II15-3464.
[0110] Figure 6 The phenotypic value of the incidence rate 25 days after inoculation with cotton wilt pathogen (physiological race 7) after silencing GbOFP7 by VIGS. R_WT represents the wild-type control of the wilt-resistant variety T10-280, and S_WT represents the wild-type control of the wilt-susceptible variety II15-3464.
[0111] Figure 7 The plant height phenotype value is 25 days after inoculation with cotton wilt pathogen (physiological race 7) after silencing GbOFP7 using VIGS. R_WT represents the wild-type control of the wilt-resistant variety T10-280, and S_WT represents the wild-type control of the wilt-susceptible variety II15-3464.
[0112] Figure 8This is a schematic diagram of the disease status 25 days after inoculation with cotton wilt pathogen (physiological race 7) after silencing GbOFP7 using VIGS. a is the plant disease phenotype; b is the leaf disease phenotype. R_WT represents the wild-type control of the wilt-resistant variety T10-280, and S_WT represents the wild-type control of the wilt-susceptible variety II15-3464.
[0113] Fig. 9 The subcellular localization of GbOFP7. Figure a shows the cellular localization of p35S::GbPP2C80-GFP in the recombinant plant carrying the GbOFP7-GFP fusion vector. Figure b shows the cellular localization of p35S::GFP in the recombinant plant carrying the GFP empty vector as a control. DETAILED DESCRIPTION
[0114] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.
[0115] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.
[0116] The quantitative experiments in the following examples were performed in triplicate unless otherwise specified.
[0117] The p35S::GFP plasmid in the following example has been described in: Zhang W, et al. Natural variations at TIG1 encoding a TCP transcription factor contribute to plant architecture domestication in Rice. Mol Plant. 2019; 12(8): 1075-1089. The public can obtain the biological material from the applicant, and the biological material is only used for repeating the experiment of the present invention and cannot be used for other purposes.
[0118] The pCLCrVA plasmid in the following example has been described in: Zhao N, et al. Genomic and GWAS analyses demonstrate phylogenomic relationships of Gossypium barbadense in China and selection for fibre length, lint percentage and Fusarium wilt resistance. Plant Biotechnol J. 2022; 20(4): 691-710. The public can obtain the biological material from the applicant, which is only used for repeating the experiments of the present invention and cannot be used for other purposes.
[0119] The 336 sea island cotton cultivars in the following examples have been recorded in: Zhao N, et al. Genomic and GWAS analyses demonstrate phylogenomic relationships of Gossypium barbadense in China and selection for fibre length, lint percentage and Fusarium wilt resistance. Plant Biotechnol J. 2022; 20(4): 691-710. The public can obtain the biological material from the applicant, which is only used for repeating the experiments of the present invention and cannot be used for other purposes.
[0120] The susceptible varieties (S) II15-3464 and the resistant varieties (R) T10-280 of sea island cotton in the following examples have been recorded in: Zhao N, et al. Genomic and GWAS analyses demonstrate phylogenomic relationships of Gossypium barbadense in China and selection for fibre length, lint percentage and Fusarium wilt resistance. Plant Biotechnol J. 2022; 20(4): 691-710. The public can obtain the biological material from the applicant, and the biological material is only used for repeating the experiments of the present invention and cannot be used for other purposes.
[0121] The physiological race 7 of Fusarium wilt in the following example has been recorded in: Zhao N, et al. Genomic and GWAS analyses demonstrate phylogenomic relationships of Gossypium barbadense in China and selection for fibre length, lint percentage and Fusarium wilt resistance. Plant Biotechnol J. 2022; 20(4): 691-710. The public can obtain the biological material from the applicant, and the biological material is only used for repeating the experiment of the present invention and cannot be used for other purposes.
[0122] The Nicotiana benthamiana in the following examples was donated by Sun Chuanqing's laboratory at China Agricultural University and has been recorded in: Zhang W, et al. Natural variations at TIG1 encoding a TCP transcription factor contribute to plant architecture domestication in Rice. Mol Plant. 2019; 12(8): 1075-1089. The public can obtain the biological material from the applicant. The biological material is only used to repeat the experiments of the present invention and cannot be used for other purposes.
[0123] The following examples use IBM SPSS_Statistics_25 statistical software to process the data. The experimental results are expressed as mean values and tested using T-Test. P<0.05 (*) indicates a significant difference, P<0.01 (**) indicates an extremely significant difference, and P<0.001 (***) indicates an extremely significant difference.
[0124] Example 1: Genome-wide association analysis to mine sea island cotton wilt resistance genes
[0125] The 336 sea island cotton accessions sequenced by the Joint Laboratory of International Cooperation in Crop Molecular Breeding of China Agricultural University and the Institute of Economic Crops of Xinjiang Academy of Agricultural Sciences were used as the positioning population, and genome-wide association analysis was performed on SNP variants with a minimum allele frequency of less than 0.05 and a deletion ratio of less than 20%. The wilt incidence data of 336 sea island cotton accessions in the Korla disease nursery in Xinjiang Uygur Autonomous Region in 2015, 2016, 2018 and 2019 showed continuous quantitative genetic characteristics ( Figure 1). The whole genome efficient mixed model association software GEMMA 0.94.1 (http: / / www.xzlab.org / software.html) was used to perform trait association analysis using a mixed linear model. The GEMMA software parameters were set to “gemma-bfile file-k kinship-lmm 1-o outfile-miss 0.2-maf 0.05-ccovariates(GCTA:PCA)”. The R package qqman was used to make a Manhattan plot. The effect value of the gene marker was detected by F-test, and the Bonferroni correction was used to correct for multiple tests. The SNPs significantly associated with wilt resistance were screened by the significance of the association (P-value). The BLUP value based on the four-year wilt incidence phenotype was located on chromosome D03 to a threshold (-log 10 The significant association locus Gbar_D03_1110567 (P-value) was 11.57 Figure 2 In a), 22.6 kb downstream is the gene Gbar_D03G001640 (named GbOFP7). In the only exon of the gene GbOFP7, there is a key non-synonymous mutation (Gbar_D03_1134219, Figure 2 b), that is, a guanine G mutates to a cytosine C, resulting in a glycine (G) mutating to an alanine (A) ( Figure 3 ). The GbOFP7 gene is derived from the sea island cotton wilt resistant variety T10-280. The GbOFP7 gene coding sequence (CDS) is SEQ ID No.1, the genome sequence is SEQ ID No.2, the protein encoded by it is named GbOFP7 protein or protein GbOFP7, and the amino acid sequence of the encoded protein is shown in SEQ ID No.3. Among them, the sea island cotton variety with genotype C at the 1007th position of the coding sequence of the GbOFP7 gene (sequence 1) has a significantly lower incidence of wilt than the sea island cotton variety with genotype G at the 1007th position ( Figure 4 ), that is, the wilt incidence of the sea island cotton varieties with alanine at position 336 of the amino acid sequence of GbOFP7 protein (sequence 3) was significantly lower than that of the sea island cotton varieties with glycine at position 336. It was speculated that GbOFP7 was a major gene regulating the resistance to Fusarium wilt in sea island cotton.
[0126] Example 2: VIGS verification of the effect of GbOFP7 on resistance to Fusarium wilt in Sea Island cotton
[0127] 1. Analysis of differential expression of GbOFP7 and determination of VIGS conversion receptor
[0128] The susceptible Sea Island cotton variety (S) II15-3464 and the highly resistant Sea Island cotton variety (R) T10-280 were planted in pots with a 1:1 mixture of nutrient soil and vermiculite. After the cotyledons were flattened, about two weeks later, the wilt bacteria were inoculated by the root wound method, and the bacterial solution concentration reached 1×10 7 Pieces / cm 2 25 days after inoculation, the leaves of the sea island cotton were taken, RNA was extracted, and reverse transcriptase was used to reverse transcribe it into cDNA. Using the cDNA as a template, specific primers were designed (forward primer CGACGTTGGAGTTTCACTGGGA; reverse primer TGGTGGTGGGAATGAATCGTCG), and real-time PCR was used to detect the expression difference of GbOFP7 in disease-resistant and disease-susceptible sea island cotton materials.
[0129] The results showed that the expression level of GbOFP7 in the susceptible sea island cotton material II15-3464 was significantly higher than that in the resistant sea island cotton material T10-280 ( Figure 5 ), therefore, VIGS transformation was performed in susceptible material II15-3464.
[0130] 2. VIGS vector construction and identification of resistance to Fusarium wilt
[0131] According to the coding sequence of gene GbOFP7, primers were designed for VIGS vector construction, and a Spe I restriction site (ACTAGT) and a protective base GG were added to the 5' end of the forward primer. The specific nucleotide sequence of the forward primer was: 5'-GGACTAGTTAATCTCCCATCAAATCCTGTC-3'; a Pac I restriction site (TTAATTAA) and a protective base CC were added to the 5' end of the reverse primer. The specific nucleotide sequence of the reverse primer was: 5'-CCTTAATTAAGCTTTCGCTGCTGAACAA-3'.
[0132] The structure of the recombinant plasmid pCLCrVA-GbOFP7 is described as follows: a recombinant vector obtained by replacing the fragment between the Spe I and Pac I recognition sites of the pCLCrVA vector sequence with the DNA molecule shown in SEQ ID No.4 while keeping the other nucleotides of the pCLCrVA vector (starting vector) unchanged.
[0133] After the recombinant vector pCLCrVA-GbOFP7 was constructed, it was heat-shocked and transformed into the Agrobacterium GV3101 strain (Sangon Biotech Co., Ltd., B528430), and the Agrobacterium tumefaciens culture containing the pCLCrVA-GbOFP7 plasmid and the Agrobacterium GV3101 containing the pCLCrVA-GbOFP7 plasmid were obtained, which were named Agrobacterium tumefaciens GV3101 / pCLCrVA-GbOFP7. The empty vector pCLCrVA was heat-shocked and transformed into the Agrobacterium GV3101 strain to obtain GV3101 / pCLCrVA as an empty vector control. The vector pCLCrVB was heat-shocked and transformed into the Agrobacterium GV3101 strain to obtain GV3101 / pCLCrVB, which was mixed with the Agrobacterium culture containing GV3101 / pCLCrVA-GbOFP7 and GV3101 / pCLCrVA in equal volumes before transformation.
[0134] 3. Obtaining GbOFP7 gene silenced transgenic sea island cotton plant S_pCLCrVA-GbOFP7
[0135] The susceptible material II15-3464 of sea island cotton was planted as the transgenic recipient using the soil culture method, and the disease-resistant variety T10-280 was planted as the disease-resistant control. Two weeks later, the cotyledons were completely flattened and transformed. The strains GV3101 / pCLCrVA-GbOFP7, GV3101 / pCLCrVA and GV3101 / pCLCrVB were cultured at 28°C until the logarithmic growth phase; centrifuged at 8000rpm for 5min, the cells were collected, and then infected with VIGS solution (10mM MES, 200μM AS, 10mM MgCl 2 ) Resuspend the cells and adjust the concentration of the bacterial solution to OD 600 = about 1.0; GV3101 / pCLCrVA-GbOFP7, GV3101 / pCLCrVA and GV3101 / pCLCrVB bacterial solutions were mixed at a volume ratio of 1:1, left to stand at room temperature for 3 hours, and then used to transform cotton leaves. The mixed bacterial solution of GV3101 / pCLCrVA and GV3101 / pCLCrVB was used as an empty vector control. Use a 1mL sterile syringe to draw up the bacterial solution and inject it into the back of the cotyledon. The injected cotton plants were placed in a 28℃ greenhouse with a 16h / 8h light-dark cycle.
[0136] Two weeks later, Fusarium oxysporum f. sp. Vasinfectum race 7 was inoculated by the root wound method. 25 days after inoculation, the disease phenotype was observed, and samples were taken to detect the silencing efficiency of the candidate gene by Real-time PCR (forward primer 5'-CGACGTTGGAGTTTCACTGGGA-3'; reverse primer 5'-TGGTGGTGGGAATGAATCGTCG-3').
[0137] The results showed that the transcription of GbOFP7 was significantly inhibited after VIGS treatment ( Figure 5 ), the incidence of Fusarium wilt in GbOFP7-silenced susceptible sea island cotton plants S_pCLCrVA-GbOFP7 was significantly reduced ( Figure 6 and Figure 8 b), which shows that GbOFP7 can negatively regulate the resistance of sea island cotton to Fusarium wilt. In addition, the plant height of the susceptible sea island cotton plant S_pCLCrVA-GbOFP7, in which GbOFP7 was silenced, increased significantly, approaching that of the disease-resistant material R_WT (T10-280) ( Figure 7 and Figure 8 (a)
[0138] Example 3: Subcellular localization of GbOFP7
[0139] According to the gene ID of GbOFP7, the CDS sequence was obtained, and primers were designed. A Kpn I restriction site (GGTACC) was added to the 5' end of the forward primer, and the nucleotide sequence of the forward primer was (5'-3'): 5'-GGTACCATGGCGAAACGATTCAAGTTCAC-3'; an Xba I restriction site (TCTAGA) was added to the 5' end of the reverse primer, and the nucleotide sequence of the reverse primer was (5'-3'): 5'-TCTAGAATTTAACCCACAAGAAACTCGAAA-3'. The cDNA of the leaf of sea island cotton was used as a template to amplify the target sequence and obtain the coding sequence of the gene of GbOFP7 (the nucleotide sequence is from the 1st to the 1056th position of sequence 1 in the sequence list (i.e., excluding the last stop codon TGA).
[0140] The purified coding sequence of the GbOFP7 gene and the p35S::GFP plasmid DNA were double-digested, and the digested products were connected to construct the p35S::GbOFP7-GFP recombinant plasmid, which was then transformed into Agrobacterium GV3101 to obtain the recombinant Agrobacterium GV3101 / GbOFP7-GFP.
[0141] The structure of the p35S::GbOFP7-GFP recombinant plasmid is described as follows: the small fragment between the restriction endonuclease Kpn I and Xba I recognition sequences of the plasmid p35S::GFP is replaced with the DNA molecule shown in sequence 1 in the sequence table (excluding the final stop codon TGA). The recombinant plasmid p35S::GbOFP7-GFP expresses the GbOFP7 protein shown in sequence 3 in the sequence table. The recombinant plasmid p35S::GbOFP7-GFP contains an expression cassette for the GbOFP7-GFP fusion protein, and the promoter for initiating transcription of the GbOFP7 gene in the expression cassette is the 35S promoter.
[0142] The p35S::GFP plasmid was directly transformed into Agrobacterium GV3101 using the same transformation method to obtain recombinant Agrobacterium GV3101 / GFP. The recombinant Agrobacterium GV3101 / GFP was used as a control for subsequent experiments.
[0143] The recombinant Agrobacterium GV3101 / GbOFP7-GFP positive bacterial solution was added to the YEP liquid medium containing 50 μg / mL Kan and 50 μg / mL Rif, and the strain was activated in a shaker (28°C, 160 rpm). 1 mL of the activated bacterial solution was added to 20 mL of the YEP liquid medium containing 50 μg / mL Kan and 50 μg / mL Rif, and the culture was expanded to OD 600 =1.0, centrifuge at 5000 rpm for 5 min to collect the bacterial solution, add suspension (containing 10 mM MES, 10 mM MgCl 2 , pH = 5.2, 100 μM AS) to resuspend the cells to OD 600 =1.0, let stand at room temperature for 2-5h.
[0144] Nicotiana benthamiana with good growth condition was selected, and the recombinant Agrobacterium GV3101 / GbOFP7-GFP suspension containing GbOFP7-GFP was gently injected into the back of tobacco leaves with a syringe. The Agrobacterium GV3101 / GFP bacterial suspension containing GFP empty vector was used as a control and injected into the lower epidermis of Nicotiana benthamiana leaves. After 24 hours of dark treatment and 48 hours of light culture, the subcellular localization of GbOFP7 protein was observed using a Zeiss LSM 880 inverted confocal fluorescence microscope, with excitation light of 488nm and emission light of 510nm.
[0145] The results are as follows Fig. 9 As shown in a and b, the GFP signal of the GbOFP7-GFP fusion protein is localized on the cell membrane and the nucleus, indicating that GbOFP7 may play a role on the cell membrane and in the nucleus.
[0146] The present invention has been described in detail above. For those skilled in the art, without departing from the purpose and scope of the present invention, and without the need to carry out unnecessary experimental conditions, the present invention can be implemented in a wide range under equivalent parameters, concentrations and conditions. Although the present invention provides specific embodiments, it should be understood that the present invention can be further improved. In a word, according to the principles of the present invention, the application is intended to include any changes, uses or improvements to the present invention, including departure from the disclosed scope in the application, and changes made with conventional techniques known in the art.
Claims
1. Application, characterized in that: The application is any of the following: U1) Application of substances that regulate the expression of protein-coding genes in enhancing cotton resistance to Fusarium wilt; U2) Use of substances that regulate the expression of protein-coding genes in the preparation of products that enhance cotton resistance to Fusarium wilt; U3) Application of substances regulating the expression of protein-coding genes in breeding cotton resistant to Fusarium wilt; U4) Use of substances that regulate the expression of protein-coding genes in the preparation of products for breeding cotton resistant to Fusarium wilt; U5) Application of substances for regulating the expression of protein-coding genes in cotton breeding for resistance to wilt disease; The protein is a protein whose amino acid sequence is shown in SEQ ID No.3; The substance that regulates the expression of the protein-coding gene is a substance that silences the expression of the protein-coding gene, and the substance that silences the expression of the protein-coding gene is any one of the following: C1) the nucleic acid molecule shown in SEQ ID No.4; C2) an expression cassette containing the nucleic acid molecule described in C1); C3) a recombinant vector containing the nucleic acid molecule described in C1), or a recombinant vector containing the expression cassette described in C2); C4) A recombinant microorganism containing the nucleic acid molecule described in C1), or a recombinant microorganism containing the expression cassette described in C2), or a recombinant microorganism containing the recombinant vector described in C3).
2. The use according to claim 1, characterized in that: C3) The recombinant vector is a pCLCrVA vector sequence Spe I and Pac The fragment between the I recognition sites is replaced with the DNA molecule shown in SEQ ID No.4, and the other nucleotides of the pCLCrVA vector are kept unchanged to obtain a recombinant vector.
3. A method for regulating plant wilt resistance, characterized in that: The method comprises regulating the activity and / or content of a protein in a target plant, or / and regulating the expression of a gene encoding the protein to regulate plant resistance to Fusarium wilt; the protein is a protein whose amino acid sequence is shown in SEQ ID No. 3; The regulation is the activity and / or content of the protein in the target plant, or / and, regulating the expression level of the gene encoding the protein includes introducing a nucleic acid molecule that inhibits, reduces or silences the gene encoding the protein into the recipient plant to improve the plant's resistance to Fusarium wilt, and the plant is cotton.
4. A method for breeding plants with altered resistance to plant wilt disease, comprising: The invention relates to a method for obtaining a plant with improved resistance to wilt disease by inhibiting or reducing the expression level of a gene encoding a protein in a target plant, or silencing a gene encoding a protein in the target plant, or / and inhibiting or reducing the activity and / or content of a gene encoding the protein; the plant with improved resistance to wilt disease has higher resistance to wilt disease than the target plant; the protein is a protein whose amino acid sequence is shown in SEQ ID No. 3; and the plant is cotton.
